Skip to content

Public FDA record

Z-1388-05: Access Immunoassay Systems Assay Protocol: Dil-AFP.

Recall record Z-1388-05 for Beckman Coulter Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1388-05
Company in FDA record
Beckman Coulter Inc
FDA classification date
Aug 23, 2005
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Pipetting for dil-Alpha-fetoprotein when performed on the Access, Access 2 and Synchron LX i 725 has a potential to create splashing which may cause erroneous results.

Source facts

Action
Letters to customers were sent July 18, 2005. Firm will upgrade software later in the year. Customers are advised to not perform the automated dilution protocol but refer to the method in the directions.
Initiated
2005-07-18
Root cause
Other
Terminated
2012-03-07
Distribution
Nationwide and Canada
Recall number
Z-1388-05
Recall status
Terminated
CDRH record ID
40748
FDA classified
2005-08-23
Recall event number
32748

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗